Acute and Chronic Effects of 100% Florida Orange Juice Consumption on Cognitive Performance in 7-10 Year Old Children

April 30, 2018 updated by: Prof Louise Dye, University of Leeds

A Study of the Acute and Chronic Effects of 100% Florida Orange Juice Consumption on Cognitive Performance in 7-10 Year Old UK School Children

This study is a 10-week intervention study to examine the acute and chronic effects of daily intake of a 100 % orange juice drink vs control drink on cognitive performance. The study aims to determine if there are any benefits of whole orange juice intake on cognitive performance acutely (i.e. an improvement in performance at week 1) and chronically (i.e. an improvement in performance at week 10).

Study Overview

Detailed Description

This study will employ a randomised 10 week, parallel groups, double blind, placebo controlled design to investigate the effects of daily supplemental orange juice compared with an equicaloric placebo orange drink on cognitive performance in 7-10 year old school children. Following screening, participants will be randomly assigned to one of two conditions: (1) Active group: 100% orange juice, (2) Placebo group: control drink (containing equivalent dose of sucrose, glucose, fructose, vitamin C and citric acid for flavour). Both the active and control groups will receive a drink daily for 10 weeks delivered as a school-based morning intervention administered by researchers. Children will also be given drinks to consume over the weekends and school holidays monitored by a drink intake diary. Participants, parents and teachers will be blind to their assigned condition. Researchers will also be blinded until completion of the data analysis.

Following a practise session at screening (week -1) to familiarise the participants with the cognitive tests and study drinks, participants will take part in 3 test sessions - at baseline (Week 0), on Day 1 of intervention (start of Week 1; acute effects) and immediately post intervention (end of Week 10; chronic effects).

At week -1 (screening) children will be tested for colour blindness (Ishihara test) and complete the Wechsler abbreviated scale of intelligence (WASI) for screening purposes. Respiratory peak flow, height, and weight will also be measured to examine the relationship between cognitive performance and physical activity.

This study design, including both the test day and morning juice supplementation, is intended to emulate the children's normal routine as far as possible. Each carton of juice will be provided mid-morning to act as a supplement to their usual diet.

Measures:

The cognitive tests included in the study are listed below:

  • Immediate and delayed picture recognition
  • Delayed spatial memory
  • Tower of Hanoi (executive function - planning/strategy)
  • Corsi block tapping test (executive function and working memory)

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Yorkshire
      • Leeds, West Yorkshire, United Kingdom, LS29JT
        • Human Appetite Research Unit, University of Leeds

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 10 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female, aged 7-10 years
  • Willingness to consume test drinks during the study (determined by a score of 5 on the taste testing Likert scale for both orange juice drinks [attached])
  • Ability to follow verbal and simple written instructions in English
  • Ability to give written consent
  • Normal vision, with appropriate corrective lenses if required
  • Ability to understand cognitive testing instructions and responding requirements

Exclusion Criteria:

  • Poor general health
  • Colour blindness (to be assessed at screening using Tests for Colour Blindness (Isihara, 1951)
  • Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder)
  • Learning disabilities which interfere with the ability to understand written or verbal communications
  • Inability to understand the objective of the cognitive tests, or carry out the tests
  • Any food allergies or intolerances to study drinks
  • Acute illness, or feelings of unwell, within the week prior to testing
  • Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing
  • Hearing impairment that precludes the ability to follow verbal instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 100% OJ
240ml 100% Florida Orange Juice consumed on a daily basis for 10 weeks.
Placebo Comparator: Equicaloric Orange Drink
An equicaloric placebo orange drink (containing equivalent dose of sucrose, glucose, fructose, vitamin C and citric acid for flavour) consumed daily for 10 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Immediate and delayed picture recognition
Time Frame: Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption
Primary dependent variable: number of pictures successfully recalled (from 20 presented) immediately following presentation and after a delay consisting of two cognitive tests (Corsi Tapping and Tower of Hanoi).
Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delayed spatial memory
Time Frame: Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption
Primary dependent variable: number of spatial patterns successfully recognised from initial presentation (14 patterns presented twice). Recognition memory paradigm showing participants two patterns; one which was shown in the presentation phase and one which was not and requesting the participant select the presented pattern. Between presentation and recognition phases the participants engaged in a Corsi tapping test and a Tower of Hanoi test.
Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption
Tower of Hanoi (executive function)
Time Frame: Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption
Executive function - planning/strategy. Primary dependent variables: number of correctly solved puzzles and number of errors. Participants complete 2 trials at 8 levels of difficulty (difficulty indexed by number of moves required to complete the puzzle).
Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption
Corsi block tapping test (Executive function and working memory)
Time Frame: Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption
Executive function and working memory. Primary dependent variables: number of correctly recalled "block" presentations. An array of 9 white boxes are presented. Individual boxes are illuminated in sequences of increasing number of target presentations (2 - 8 boxes illuminated). After each pattern sequence is completed, participants are presented with the blank array of white boxes and are required to repeat the pattern in sequential order.
Acute = 3 hours post first consumption. Chronic = After 10 weeks daily consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Clare Lawton, PhD, University of Leeds

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

March 22, 2016

First Submitted That Met QC Criteria

March 28, 2016

First Posted (Estimate)

April 1, 2016

Study Record Updates

Last Update Posted (Actual)

May 2, 2018

Last Update Submitted That Met QC Criteria

April 30, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • RFP 15-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on 100% Florida OJ

3
Subscribe